1. Medtech Insight
  2. >>Business

Dealmaking: Q3 Roundup Shows Deal Values Jump From Prior Quarter

A look at M&A and alliance activity across the medical device and in vitro diagnostics industries, July-September 2020

 
• By Deanna Kamienski and Maureen Riordan

Device company M&A values reached $17.9bn in Q3, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $8.2bn.

M and A diagram, Businessman hand touching M&A (Merger and Acquisition) sign on virtual screen

Featuring 24 completed device M&A transactions, half of which had disclosed values together totaling $17.9bn, the third quarter showed an exponential increase in deal value (and deal volume also notably rose) from Q2’s $159m (for five completed deals; see Exhibit 1). At the top, making up 92% of the Q3 total was Siemens Healthineers AG’s definitive agreement to acquire public radiotherapy developer Varian Medical Systems, Inc.. in an all-cash transaction valued at $16.4bn. ([A#MT142548])

Even without this transaction, the Q3 deal value, at $1.5bn, was still almost 10 times more than the previous quarter.

More from Deals

More from Business

Aneira Health Launches New Precision Medicine Platform Exclusively For Women

 
• By Natasha Barrow

Cecilia Lindgren, Aneira Health’s co-founder and chief science officer, said that the company has “redesigned the diagnostic model.” The subscription-based platform offers clinical-grade and AI diagnostics alongside clinical consultation.

Thermo Fisher Cuts Annual Profit Outlook Amid Estimated $400M Tariff Hit

 
• By Shubham Singh

Thermo Fisher is aggressively managing its supply chain and cost base using its Practical Process Improvement (PPI) Business System. The company is also increasing investments in US-based manufacturing and R&D, with around $2bn allocated to bolster domestic operations.

‘Small Business’ Applications For Waiver Of Device User Fees To Be Streamlined By US FDA

 
• By Brian Bossetta

FDA moves forward with implementing previous draft guidance and will consolidate forms, but the agency estimates limited impact in the total reporting burden.